Institutional Ownership Revolution Medicines, Inc. (RVMD)
This table provides information about the institutional ownership of Revolution Medicines, Inc. (RVMD). We have compiled data on the 331 institutions that hold shares in the stock, with a total of 195 Million shares, which have been reported (via 13F filing form) to have a value of $6.87 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
15,761,691
shares
|
$556 Million
0.01% of portfolio
|
Q2 2025
Reduced 5.12%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
14,325,692
shares
|
$505 Million
2.37% of portfolio
|
Q2 2025
Added 5.84%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,408,713
shares
|
$473 Million
0.01% of portfolio
|
Q2 2024
Added 8.94%
|
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
10,590,727
shares
|
$373 Million
0.2% of portfolio
|
Q2 2025
Added 3.93%
|
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
10,259,738
shares
|
$362 Million
0.07% of portfolio
|
Q2 2025
Reduced 12.96%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
9,364,972
shares
|
$330 Million
3.49% of portfolio
|
Q2 2025
Added 17.99%
|
|
|
Nextech Invest, Ltd.
Zurich, V8 |
Aug 14, 2025 Q2 2025 |
7,601,087
shares
|
$268 Million
52.92% of portfolio
|
Q1 2025
New holding
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
7,601,087
shares
|
$268 Million
61.97% of portfolio
|
Q4 2024
Added 20.71%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
6,093,291
shares
|
$215 Million
10.46% of portfolio
|
Q2 2025
Reduced 1.37%
|
|
|
Bvf Inc
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
4,982,384
shares
|
$176 Million
7.2% of portfolio
|
Q1 2025
Added 19.16%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,718,906
shares
|
$166 Million
0.01% of portfolio
|
Q2 2025
Reduced 18.71%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
4,701,962
shares
|
$166 Million
0.02% of portfolio
|
Q2 2025
Reduced 16.03%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
4,689,298
shares
|
$165 Million
0.11% of portfolio
|
Q2 2025
Added 180.22%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Aug 14, 2025 Q2 2025 |
4,579,300
shares
|
$161 Million
3.83% of portfolio
|
Q2 2025
Added 4.69%
|
|
|
Alphabet Inc.
Mountain View, CA |
Jul 31, 2025 Q2 2025 |
4,133,277
shares
|
$146 Million
9.86% of portfolio
|
Q4 2024
Reduced 2.89%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
3,702,909
shares
|
$131 Million
0.01% of portfolio
|
Q1 2025
Reduced 3.3%
|
|
|
Holocene Advisors, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,632,952
shares
|
$128 Million
0.35% of portfolio
|
Q2 2025
Reduced 1.59%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
3,384,072
shares
|
$119 Million
2.86% of portfolio
|
Q2 2025
Added 2.01%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,993,866
shares
|
$106 Million
0.01% of portfolio
|
Q2 2025
Reduced 27.73%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
2,915,572
shares
|
$103 Million
0.61% of portfolio
|
Q2 2025
Reduced 24.99%
|
|
|
Casdin Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,887,933
shares
|
$102 Million
14.89% of portfolio
|
Q2 2025
Reduced 21.9%
|
|
|
Lunate Holding Rsc LTD
Al Maryah Island, Abu Dhabi, C0 |
Feb 14, 2025 Q4 2024 |
2,196,200
shares
|
$77.4 Million
45.54% of portfolio
|
Q4 2024
New holding
|
|
|
Lunate Capital LTD
Al Maryah Island, Abu Dhabi, C0 |
Jul 17, 2025 Q2 2025 |
2,196,200
shares
|
$77.4 Million
45.37% of portfolio
|
Q1 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
2,153,397
shares
|
$75.9 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.51%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
1,701,111
shares
|
$60 Million
0.01% of portfolio
|
Q2 2025
New holding
|